Intramedullary tuberculoma mimicking primary CNS lymphoma

A A Mohit1, P Santiago, R Rostomily

  • 1Department of Neurological Surgery, University of Washington School of Medicine, Seattle, USA. abmohit@u.washington.edu

Insights

Primary central nervous system lymphoma (PCNSL) diagnosis in AIDS patients using Epstein-Barr virus (EBV) PCR assays can lead to misdiagnosis. Histological confirmation is crucial before initiating therapy to avoid incorrect treatment for conditions like tuberculoma.

Area of Science:

  • Neuro-oncology
  • Infectious Diseases
  • Diagnostic Pathology

Background:

  • Primary central nervous system lymphoma (PCNSL) incidence is increasing in immunocompromised individuals, notably those with acquired immune deficiency syndrome (AIDS).
  • Cerebrospinal fluid (CSF) Epstein-Barr virus (EBV) PCR assays have become a primary diagnostic tool for PCNSL, often supplanting traditional methods like CNS biopsy due to high reported sensitivity and specificity.

Observation:

  • A patient with a history of C3 AIDS presented with neurological symptoms including lower extremity weakness and myelopathy.
  • Initial diagnosis of intramedullary PCNSL was made based on the detection of EBV DNA in the CSF.

Findings:

  • The patient did not respond to radiotherapy, prompting further investigation.
  • A subsequent spinal cord biopsy revealed an intramedullary tuberculoma, indicating a misdiagnosis based on the CSF EBV PCR assay.

Implications:

  • This case highlights the potential for misdiagnosis when relying solely on CSF EBV PCR assays for PCNSL in immunocompromised patients.
  • Emphasizes the critical importance of histological confirmation of lesions before commencing treatment to ensure accurate diagnosis and appropriate therapy, especially in cases of suspected PCNSL.
  • Underscores the need for a comprehensive diagnostic approach, integrating molecular assays with histopathology, particularly in complex cases within the context of immunodeficiency syndromes.